Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Medtronic reports positive CoreValve data
Mass Device
Wednesday, October 15, 2014 - 12:24pm
tags:
Medtronic, devices, CoreValve, aortic valve replacement
Supreme Court seems divided in patent dispute over best-selling multiple sclerosis drug
Yahoo/AP
Wednesday, October 15, 2014 - 12:23pm
tags:
Supreme Court, generics, multiple sclerosis, MS, Teva Pharmaceutical, Copaxone
What Does Closing the ‘Double Irish’ Tax Loophole Mean for Pharma?
WSJ Pharmalot
Wednesday, October 15, 2014 - 11:33am
tags:
Ireland, tax inversions
Can Amgen's marketing muscle vault its Humira biosim ahead of rivals?
Fierce Pharma Marketing
Wednesday, October 15, 2014 - 11:13am
tags:
Amgen, biosimilars, Humira, ABP 501, Novartis, Boehringer Ingelheim
Selecta banks $20M for trial work, inks a pact with Sanofi on diabetes
Fierce Biotech
Wednesday, October 15, 2014 - 9:24am
tags:
Sanofi, Selecta, vaccines
St.Jude Medical adjusted profit rises
Yahoo/Reuters
Wednesday, October 15, 2014 - 8:59am
tags:
St. Jude Medical, devices, earnings
FDA approves expanded label for Lymphoseek
Seeking Alpha
Wednesday, October 15, 2014 - 8:10am
tags:
FDA, Lymphoseek, Navidea Biopharmaceuticals
Shire says AbbVie should not renege on merger deal
Yahoo/Reuters
Wednesday, October 15, 2014 - 8:07am
tags:
Shire, AbbVie, M&A, tax inversions
Medgenics posts third-quarter loss of $3 million
Yahoo/AP
Wednesday, October 15, 2014 - 8:04am
tags:
Medgenics, earnings
Will an FDA Policy Shift on Fixed-Dose Drug Approvals Anger Pharma?
WSJ Pharmalot
Tuesday, October 14, 2014 - 9:26pm
tags:
drug approvals, FDA
A Quick Look at Pfizer Inc.'s Drug Development Pipeline
Motley Fool
Tuesday, October 14, 2014 - 9:24pm
tags:
Pfizer
Astellas dives into gene therapy with a Harvard expert in tow
Fierce Biotech
Tuesday, October 14, 2014 - 9:23pm
tags:
Astellas, gene therapy, Retinitis pigmentosa
AbbVie Board to Reconsider Recommendation for Shire Deal
Bloomberg
Tuesday, October 14, 2014 - 9:19pm
tags:
AbbVie, Shire, M&A
J&J hikes 2014 forecast for a third time
Yahoo/AP
Tuesday, October 14, 2014 - 1:08pm
tags:
JNJ
Medtronic Begins Study of First Predictive Low Glucose Management Technology-Critical Step in Development of Artificial Pancreas
Yahoo
Tuesday, October 14, 2014 - 11:32am
tags:
Medtronic, devices, artificial pancreas
Concert Pharmaceuticals' Spasticity Drug Gets Positive Reviews
Drug Discovery and Development
Tuesday, October 14, 2014 - 11:25am
tags:
Concert Pharmaceuticals, spasticity, CTP-354
Gilead Sciences Falls Amid Worries Over Hep-C Drug Price
TheStreet.com
Tuesday, October 14, 2014 - 11:22am
tags:
Gilead Sciences, hepatitis C, drug pricing, Harvoni
Management Incentives Could Be Bonus For AstraZeneca
WSJ Online
Tuesday, October 14, 2014 - 11:16am
tags:
AstraZeneca, executive pay
GW Pharma's cannabis-based drug comes up short in ulcerative colitis
Fierce Biotech
Tuesday, October 14, 2014 - 10:15am
tags:
GW Pharma, ulcerative colitis, GWP42003
Retrophin sells non-core assets
Seeking Alpha
Tuesday, October 14, 2014 - 10:13am
tags:
Retrophin

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.